Women's views on autologous cell-based therapy for post-obstetric incontinence

Open Access Research Article surveying parous women’s thoughts on potential autologous cell-based therapies for fecal and urinary incontinence that arises due to pelvic diaphragm tearing during vaginal childbirth, by Bernice Wright, Richard Day et al. from University College Hospital (UK).

Thumb graphic clean
Apr 08, 2016

Fecal incontinence and stress urinary incontinence are distressing and life-limiting conditions that can affect women after childbirth, caused by pelvic diaphragm muscles, nerves or connective tissues being torn during vaginal childbirth. Therapeutic strategies to address these symptoms are generally not curative; however, recent preclinical and early-stage clinical studies suggest that autologous cell-based therapies could help repair the damage associated with fecal incontinence and stress urinary incontinence.

This Open Access Research Article aimed to investigate women's opinions on cell-based incontinence therapies. The authors generated a multiple choice questionnaire to assess whether or not primiparous and multiparous women would consider complex specialist evaluation and treatment following perineal birth trauma, and the results indicated that autologous cell-based therapies for birth injury incontinence would likely be accepted by the patients.

Wright B, Emmanuel A, Athanasakos E et al. Women's views on autologous cell-based therapy for post-obstetric incontinence. Regen. Med. 11(2), 169–180 (2016).

Women's views on autologous cell-based therapy for post-obstetric incontinence

Medium graphic clean

Regenerative Medicine

Journal, Future Science Group

Regenerative Medicine is an award-winning peer-reviewed journal, in print and web formats. The journal provides a forum to address the important challenges and advances in stem cell research and regenerative medicine, delivering this essential information in concise, clear and attractive article formats. Among other indexing services Regenerative Medicine is listed by MEDLINE/Index Medicus, EMBASE/Excerpta Medica, Chemical Abstracts, Science Citation Index Expanded™ (SciSearch®), Emcare, Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index®, Journal Citation Reports/Science Edition®, Scopus® with an Impact Factor of 2.786 (2014). Each issue contains expertly drafted Reviews, Original Research articles, Perspectives, Editorials, topical insight from international leaders in their field, and additional added-value content. The Senior Editor of the journal is Professor Chris Mason, University College London. You can find out more about Regenerative Medicine at our website (www.future-science-group.com/journalprofile/regenerative-medicine/), where you can find the aims and scope of the journal and details of our international editorial board.

No comments yet.